Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | 0ZM2Z182GD |
InChI Key | CWHUFRVAEUJCEF-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C18H21F3N6O2 |
Molecular Weight | 410.4 |
AlogP | 1.81 |
Hydrogen Bond Acceptor | 8.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 3.0 |
Polar Surface Area | 89.63 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 29.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | PI3-kinase class I inhibitor | PubMed |
Primary Target | |
---|---|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Kinase
Protein Kinase
Atypical protein kinase group
Atypical protein kinase PIKK family
Atypical protein kinase FRAP subfamily
|
- | 94-4600 | 19 | 199 | - | |
Enzyme
Kinase
Protein Kinase
Atypical protein kinase group
Atypical protein kinase PIKK family
|
- | 94-4600 | 1800 | 199 | - | |
Enzyme
Transferase
|
- | 20-216 | 130 | 20 | 82 | |
Enzyme
|
- | 20-216 | 130 | 14000 | 82 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Head and Neck Neoplasms | 3 | D006258 | ClinicalTrials |
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
Glioblastoma | 2 | D005909 | ClinicalTrials |
Melanoma | 2 | D008545 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
Thymoma | 2 | D013945 | ClinicalTrials |
Lymphoma, Mantle-Cell | 2 | D020522 | ClinicalTrials |
Neoplasms | 2 | D009369 | ClinicalTrials |
Thyroid Neoplasms | 2 | D013964 | ClinicalTrials |
Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
Esophageal Neoplasms | 2 | D004938 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
Leukemia | 1 | D007938 | ClinicalTrials |
Lymphoma, Follicular | 1 | D008224 | ClinicalTrials |
Lung Neoplasms | 1 | D008175 | ClinicalTrials |
Liver Diseases | 1 | D008107 | ClinicalTrials |
Primary Myelofibrosis | 1 | D055728 | ClinicalTrials |
Lymphoma, Large B-Cell, Diffuse | 1 | D016403 | ClinicalTrials |
Small Cell Lung Carcinoma | 1 | D055752 | ClinicalTrials |
Gastrointestinal Stromal Tumors | 1 | D046152 | ClinicalTrials |
Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
Kidney Diseases | 1 | D007674 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 944396-07-0 |
ChEBI | 71954 |
ChEMBL | CHEMBL2017974 |
DrugBank | DB11666 |
EPA CompTox | DTXSID50241486 |
FDA SRS | 0ZM2Z182GD |
Guide to Pharmacology | 7878 |
PDB | SD5 |
PubChem | 16654980 |
SureChEMBL | SCHEMBL146956 |
ZINC | ZINC000043154039 |